Medical Condition News

RSS

CardioNova initiates Phase 1b clinical trial with AtheroNova's AHRO-001

AtheroNova Inc., a biotech company focused on the research and development of compounds to safely regress atherosclerotic plaque and improve lipid profiles in humans, today announces that its partner, CardioNova, has accomplished first dosing of subjects for its Phase 1b clinical trial with AtheroNova's lead compound, AHRO-001.

30 Jul 2014

More accurate tests could be created to diagnose memory problems

UEA research finds hope for more accurate diagnosis of memory problems. More accurate tests could be created to diagnose diseases such as Alzheimer's or memory problems stemming from head injuries, leading to earlier intervention, according to new findings from the University of East Anglia (UEA).

30 Jul 2014

New anesthesia procedure demonstrates cause of obstruction in patients with severe sleep apnea

A simplified anesthesia procedure may enable more widespread use of preoperative testing to demonstrate the cause of airway obstruction in patients with severe sleep apnea, suggests a study in Anesthesia & Analgesia.

30 Jul 2014

Researchers establish new strategy to help surgeons see entire tumor in patient

The best way to cure most cases of cancer is to surgically remove the tumor. The Achilles heel of this approach, however, is that the surgeon may fail to extract the entire tumor, leading to a local recurrence.

30 Jul 2014

Running for just 10 minutes a day can reduce risk of death

Need an incentive to lace up your shoes and go for a run? A new Iowa State University study, published in the Journal of the American College of Cardiology, found running for just five or 10 minutes a day can significantly reduce your risk of death from cardiovascular disease.

30 Jul 2014

Researchers investigate hereditary breast cancer to find new treatment approaches

Deborah Kelly and Zhi Sheng, assistant professors at the Virginia Tech Carilion Research Institute, recently received a grant from the Commonwealth Health Research Board to investigate hereditary breast cancer, an effort that may lead to new treatment approaches.

30 Jul 2014

Brains of autistic kids are relatively inflexible at switching from rest to task performance

The brains of children with autism are relatively inflexible at switching from rest to task performance, according to a new brain-imaging study from the Stanford University School of Medicine.

30 Jul 2014

EMD Serono begins MSB0010718C Phase II study in mMCC patients

EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt, Germany, today announced the initiation of an international Phase II study designed to assess the efficacy and safety of MSB0010718C, an investigational fully human IgG1 monoclonal antibody that binds to programmed death-ligand 1 (PD-L1).

29 Jul 2014

GSK announces availability of once-weekly Tanzeum in pharmacies throughout the U.S.

GSK today announced that once-weekly Tanzeum (albiglutide), a prescription injectable treatment for type 2 diabetes in adults, as an adjunct to diet and exercise, is now available in pharmacies throughout the U.S.

29 Jul 2014

FDA approves EYLEA Injection for treatment of Diabetic Macular Edema

Regeneron Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration has approved EYLEA (aflibercept) Injection for the treatment of Diabetic Macular Edema (DME).

29 Jul 2014

FDA approves use of Imbruvica to treat patients with chronic lymphocytic leukemia

The U.S. Food and Drug Administration today expanded the approved use of Imbruvica (ibrutinib) to treat patients with chronic lymphocytic leukemia (CLL) who carry a deletion in chromosome 17 (17p deletion), which is associated with poor responses to standard treatment for CLL. Imbruvica received a breakthrough therapy designation for this use.

29 Jul 2014

Researchers find molecule that irreversibly interferes with activity of mutated cancer gene

UT Southwestern Medical Center cancer researchers have found a molecule that selectively and irreversibly interferes with the activity of a mutated cancer gene common in 30 percent of tumors.

29 Jul 2014

Healthy lifestyle may help childhood cancer survivors avoid metabolic syndrome

A new study has found that following a healthy lifestyle may lower childhood cancer survivors’ risk of developing the metabolic syndrome. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the findings indicate that children with cancer and adults who had cancer when they were children should receive information about how their lifestyle may influence their long-term health.

29 Jul 2014

New specialised clinic, smartphone app aim to improve health outcomes of chronic fatigue patients

Sufferers of Chronic Fatigue Syndrome are set to benefit with the dual launch of a specialist Griffith University clinic and smartphone app, both aimed to manage their illness and improve health outcomes.

29 Jul 2014

EMA CHMP adopts positive opinion for Janssen’s IMBRUVICA to treat CLL and MCL

Janssen-Cilag International NV announced today that the Committee for Medicinal Products for Human Use of the European Medicines Agency adopted a positive opinion recommending the granting of a marketing authorisation for IMBRUVICA (ibrutinib) in the European Union.

29 Jul 2014

Study suggests healthy diet, sleep and exercise can mitigate negative impacts of stress

A new study from UC San Francisco is the first to show that while the impact of life's stressors accumulate overtime and accelerate cellular aging, these negative effects may be reduced by maintaining a healthy diet, exercising and sleeping well.

29 Jul 2014

Taiwan researchers develop new optical device to detect early complication of diabetes sooner

A group of researchers in Taiwan has developed a new optical technology that may be able to detect an early complication of diabetes sooner, when it is more easily treated. If the device proves safe and effective in clinical trials, it may pave the way for the early detection and more effective treatment of this complication, called diabetic autonomic neuropathy, which is common among people with both Type 1 and Type 2 diabetes.

29 Jul 2014

Medical Condition News

CardioNova initiates Phase 1b clinical trial with AtheroNova's AHRO-001

More accurate tests could be created to diagnose memory problems

New anesthesia procedure demonstrates cause of obstruction in patients with severe sleep apnea

Researchers establish new strategy to help surgeons see entire tumor in patient

Running for just 10 minutes a day can reduce risk of death

Researchers investigate hereditary breast cancer to find new treatment approaches

Brains of autistic kids are relatively inflexible at switching from rest to task performance

EMD Serono begins MSB0010718C Phase II study in mMCC patients

GSK announces availability of once-weekly Tanzeum in pharmacies throughout the U.S.

FDA approves EYLEA Injection for treatment of Diabetic Macular Edema

FDA approves use of Imbruvica to treat patients with chronic lymphocytic leukemia

Researchers find molecule that irreversibly interferes with activity of mutated cancer gene

Healthy lifestyle may help childhood cancer survivors avoid metabolic syndrome

New specialised clinic, smartphone app aim to improve health outcomes of chronic fatigue patients

EMA CHMP adopts positive opinion for Janssen’s IMBRUVICA to treat CLL and MCL

Study suggests healthy diet, sleep and exercise can mitigate negative impacts of stress

Taiwan researchers develop new optical device to detect early complication of diabetes sooner

University of Bradford researchers devise simple blood test to diagnose cancer

Researchers one step closer to finding treatment for Alzheimer's, other forms of dementia

Cancer researchers find molecule that irreversibly interferes with KRAS gene

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News